Cures Start Here. At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch\u2019s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation\u2019s first cancer prevention research program, as well as the clinical coordinating center of the Women\u2019s Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Careers Start Here.
In order to fulfill its mission, Fred Hutch is dedicated to:
Generating new scientific discoveries and translating them into effective medical practices, therapies and public health approaches;
Recruiting, supporting and training highly qualified scientists and physicians in an environment that promotes collaboration and excellence;
Cooperating with other research entities and medical institutions to assure worldwide access to new research findings and technical developments;
Providing sensitive, efficient and effective care for patients participating in our experimental therapies and other studies; and
Promoting the importance of scientific research, responsible medical care, healthy environments and personal behaviors through public education and advocacy.
The scientific palette of Fred Hutch is extensive; it has over 270 research scientists and 2,800 employees. Areas of research focus include hematologic malignancies, solid tumor biology, immunotherapy, early detection, tumor research, international research, fundamental science, cancer and prevention research as well as substantial programs in global oncology and HIV/AIDS. Additionally, given that the eradication of cancer and other life-threatening diseases is an ambitious goal that demands tenacity, scientific excellence, collaboration and breakthrough creativity, Fred Hutch has five scientific divisions working toward this end: Basic Sciences, Clinical Research, Human Biology, Public Health Sciences, and Vaccine and Infectious Disease. The Center has recently established crosscutting integrated research centers organized to promote team science involving members from two or more of the scientific divisions.
IT Business Partner [Supporting the Vaccine and Infectious Disease Division (VIDD) at Fred Hutch]
The IT Business Partner (ITBP) is a strategic new role that will work closely with leaders and employees at all levels in an assigned scientific divisions, to provide support, information, guidance and consultation, and to facilitate the delivery of IT services that support research and administration. The ITBP is the primary liaison between the scientific division(s) and Center IT and is responsible for understanding the needs and complexities of the scientific divisions in finding appropriate solutions for the research teams and programs. The ideal candidate will be a strong self-starter, thrive in a fast-paced environment, have excellent communication skills and have a demonstrated ability to solve technical challenges from desktop support to information security through partnership between technical teams and business stakeholders.
At Fred Hutchinson Cancer Research Center, teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Researchers are discovering new ways to detect cancers earlier, improve treatments, and learn how to prevent cancers from growing. Although Fred Hutchinson opened its doors in 1975, its history began about 20 years before that. In 1962 Fred Hutchinson envisioned a center devoted to studying cancer, a disease that took his brother’s life. Today Fred Hutchinson is contributing to the next waves of breakthrough treatments and prevention strategies. Fred Hutchinson collaborates with the Seattle Cancer Alliance, the National Cancer Institute, and the University of Washington.